News RCGP Revalidation ePortfolio demo

RCGP chair Professor Steve Field said: ‘We had a fantastic reaction to our portfolio, with over 100 organizations, registration of primary care to become early adopters, the presentation is a great way to PCOs and GPs are familiar with our system in advance. its launch in December. We encourage mutual funds to watch the video and then review their training needs in view of the formation of ‘super user’, will give us later this year. ‘

Continue reading: News RCGP Revalidation ePortfolio demo

Newly diagnosed myeloma can be treated with the lower dose of dexamethasone

The results indicate that only 79 % of 214 patients treated with high-dose therapy and 68 % of the 205 patients at low dose had a complete or partial response within four cycles. But in the second interim analysis after one year overall survival was 96 % in the low dose of dexamethasone compared to 87 % in high-dose group. Accordingly, the trial was stopped and patients receiving high doses were crossed on low-dose therapy. A total of 117 of patients receiving high doses were grade 3 or worse toxic effects in the first four months. Against the 76 of 220 patients in the diagram at low doses for which toxicity data were available

Continue reading: Newly diagnosed myeloma can be treated with the lower dose of dexamethasone

Brisk walking can help the man with prostate cancer, a study

A previous study published earlier this year in June UCSF Chan, SCD, and colleagues at the Harvard School of Public Health, has shown that physical activity after diagnosis could reduce disease-related mortality in a distinct population of men with prostate cancer. The new study complements this finding, as was the first to focus on the effects of physical activity after diagnosis on early indications of disease progression such as increased rates of prostate specific antigen blood .

Continue reading: Brisk walking can help the man with prostate cancer, a study

Boston Scientific Platinum Chromium Stent System ™ ion shows the performance analysis of Perseus and TAXUS ATLAS clinical trial data

ION stent system offers innovative RPTC alloy stent design for greater strength, improved deliverability and visibility. The stent is designed to better fit leg slim, slight decrease, and lesion coverage and uniform distribution of the drug. The delivery system of advanced low profile facilitates the precise delivery of the stent through difficult lesions.

Continue reading: Boston Scientific Platinum Chromium Stent System ™ ion shows the performance analysis of Perseus and TAXUS ATLAS clinical trial data

Psychotherapy offers obesity prevention for ‘at risk’ teenage girls

A team of scientists Uniformed Services University of Health Sciences and the National Institutes of Health have piloted psychotherapy treatment to prevent excessive weight gain among adolescent girls considered at risk . The study, published in the International Journal of Eating Disorders, found that girls who participated in interpersonal psychotherapy may be better able to prevent their increase in BMI over a year than girls who took traditional health education courses.

Continue reading: Psychotherapy offers obesity prevention for ‘at risk’ teenage girls

Page 1 of 212